久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Efficacy test of new HIV vaccine against multiple strains to be launched

Xinhua | Updated: 2019-07-16 05:46
Share
Share - WeChat
A doctor holds a red ribbon. [Photo/IC]

WASHINGTON - The US National Institutes of Health (NIH) and Janssen Pharmaceutical Companies of Johnson & Johnson announced Monday a plan to carry out an HIV vaccine efficacy trial in North America, South America and Europe.

This Phase 3 efficacy study will enroll 3,800 HIV-negative men and transgender people aged 18 to 60 years who have sex with men and/or transgender people.

The study will evaluate an investigational vaccine called Mosaico based on "mosaic" immunogens, vaccine components comprising elements from multiple HIV subtypes, aiming to induce immune responses against a wide variety of global HIV strains.

"We are committed to developing a safe and effective preventive HIV vaccine suitable for the global populations most vulnerable to HIV acquisition," said Anthony S. Fauci, director of NIH's National Institute of Allergy and Infectious Diseases.

It is anticipated to open for enrollment in the United States later this year and the clinical research will also be done in Argentina, Brazil, Italy, Mexico, Peru, Poland and Spain, according to NIH.

"We are in the process of submitting regulatory applications to the respective Health Authorities/Ethics Committees," Corina Ramers-Verhoeven, a spokesperson with Janssen Pharmaceutical Companies, told Xinhua.

The vaccine candidate may work against multiple strains of the rapidly changing virus. Currently, there is no vaccine that could bring forth broadly neutralizing antibodies, the body's most effective protection against viruses.

Initial findings from Mosaico are expected in 2023, according to Janssen.

Mosaico will be the third HIV vaccine efficacy trial in progress worldwide. The other two are Imbokodo and HVTN 702, both being tested in African countries, according to NIH.

The World Health Organization has set a goal of ending the AIDS epidemic by 2030, and a vaccine is seen as a critical tool to achieve that goal.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 黄色综合网 | 91久久99热青草国产 | 免费一级毛片麻豆精品 | 国产成人在线播放视频 | 成人网在线免费观看 | 欧美一区二区在线观看 | 91香蕉网 | 久久综合狠狠综合狠狠 | 免费中文字幕 | 一级做a爱片特黄在线观看免费看 | 亚洲欧美日韩综合一区久久 | 欧美黄区 | 久久精品国产99国产精品 | 亚洲成人中文字幕 | 午夜一级做a爰片久久毛片 午夜伊人网 | 国产美女野外做爰 | 亚洲综合精品成人 | 国产一区二区在线观看免费 | 国产精品99久久免费观看 | 114毛片免费观看网站 | 国产午夜精品理论片在线 | 免费的特黄特色大片在线观看 | 九九免费精品视频 | 日韩欧美精品在线观看 | 永久精品免费影院在线观看网站 | 亚洲成在线 | 国产亚洲福利 | 成人午夜亚洲影视在线观看 | 国产亚洲精品九九久在线观看 | 国产成人mv 在线播放 | 99精品在线观看 | 日韩经典中文字幕 | 国产99视频在线观看 | 久草中文网 | 三级网站视频在线观看 | 久久一日本道色综合久久 | 看片亚洲 | 国产精品欧美日韩一区二区 | 亚洲高清无在码在线无弹窗 | 国产二区三区 | 国产亚洲一区呦系列 |